{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:44:08Z","timestamp":1792806248537,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.diabres.2026.113432","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:59:26Z","timestamp":1783954766000},"page":"113432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolite sensing in cardiometabolic HFpEF: mechanisms and therapeutic perspectives"],"prefix":"10.1016","volume":"239","author":[{"given":"Yajie","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113432_b0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJMcp2305181","article-title":"Heart failure with preserved ejection fraction","volume":"392","author":"Cannata","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113432_b0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.122.062874","article-title":"Cardiometabolic HFpEF: NASH of the Heart","volume":"147","author":"Capone","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113432_b0015","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","article-title":"Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX Trial Ancillary Study","volume":"94","author":"Reddy","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diabres.2026.113432_b0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113432_b0025","first-page":"2677","article-title":"Adipokines and cardiometabolic heart failure with preserved ejection fraction: a state-of-the-art review","volume":"14","author":"Theodorakis","year":"2024","journal-title":"Diagn Basel Switz"},{"key":"10.1016\/j.diabres.2026.113432_b0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41580-022-00572-w","article-title":"Metabolites as signalling molecules","volume":"24","author":"Baker","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.diabres.2026.113432_b0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-018-0024-7","article-title":"Metabolite sensing and signaling in cell metabolism","volume":"3","author":"Wang","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.diabres.2026.113432_b0040","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.7150\/thno.105894","article-title":"BCAA catabolism targeted therapy for heart failure with preserved ejection fraction","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.diabres.2026.113432_b0045","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3390\/cells10123347","article-title":"Metabolite G-Protein coupled receptors in cardio-metabolic diseases","volume":"10","author":"Strassheim","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.diabres.2026.113432_b0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature14190","article-title":"Nutrient-sensing mechanisms and pathways","volume":"517","author":"Efeyan","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2026.113432_b0055","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2026.113432_b0060","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s12276-023-01006-z","article-title":"Nutrient sensors and their crosstalk","volume":"55","author":"Sung","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.diabres.2026.113432_b0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cmet.2017.03.008","article-title":"GPCR-mediated signaling of metabolites","volume":"25","author":"Husted","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2026.113432_b0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear receptors, RXR, and the big bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2026.113432_b0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","article-title":"AMPK and TOR: the Yin and Yang of cellular nutrient sensing and growth control","volume":"31","author":"Gonz\u00e1lez","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2026.113432_b0080","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cmet.2022.10.008","article-title":"Mitochondrial signal transduction","volume":"34","author":"Picard","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2026.113432_b0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41576-020-0270-8","article-title":"The evolving metabolic landscape of chromatin biology and epigenetics","volume":"21","author":"Dai","year":"2020","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.diabres.2026.113432_b0310","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jchf.2021.11.006","article-title":"Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER Trial","volume":"10","author":"Solomon","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.diabres.2026.113432_b0315","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113432_b0320","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvae047","article-title":"SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits","volume":"120","author":"Preda","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2026.113432_b0325","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.numecd.2021.05.005","article-title":"Effects of sodium-glucose cotransporter-2 inhibitors on appetite markers in patients with type 2 diabetes mellitus","volume":"31","author":"McMillin","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"10.1016\/j.diabres.2026.113432_b0330","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113432_b0335","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacbts.2023.05.012","article-title":"The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF","volume":"8","author":"Withaar","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.diabres.2026.113432_b0340","doi-asserted-by":"crossref","unstructured":"Lu H, Kosztin A, Claggett BL, Fo\u00e0 A, Pab\u00f3n MA, Desai AS, et al. Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol 2026:e260682. doi: 10.1001\/jamacardio.2026.0682.","DOI":"10.1001\/jamacardio.2026.0682"},{"key":"10.1016\/j.diabres.2026.113432_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2026.153332","article-title":"Nonsteroidal mineralocorticoid receptor antagonist finerenone ameliorates cardiac hypertrophy with increasing glucocorticoid signaling sensitivity","volume":"802","author":"Morikawa","year":"2026","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabres.2026.113432_b0350","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/07853890.2023.2171110","article-title":"Cardiorenal benefits of finerenone: protecting kidney and heart","volume":"55","author":"Gonz\u00e1lez-Juanatey","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.diabres.2026.113432_b0220","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/CIRCRESAHA.125.326463","article-title":"Histone methyltransferase SETD2: a key player in cardiometabolic HFpEF","volume":"136","author":"Serio","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2026.113432_b0355","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/CIRCULATIONAHA.120.046462","article-title":"HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling","volume":"143","author":"Travers","year":"2021","journal-title":"circulation"},{"key":"10.1016\/j.diabres.2026.113432_b0360","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/acsptsci.3c00219","article-title":"Apabetalone (RVX-208): a potential epigenetic therapy for the treatment of cardiovascular, renal, neurological, viral, and cancer disorders","volume":"7","author":"Dhulkifle","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.diabres.2026.113432_b0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-020-01199-x","article-title":"Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study","volume":"20","author":"Nicholls","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113432_b0370","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3389\/fphar.2019.01360","article-title":"Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target","volume":"10","author":"Yang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabres.2026.113432_b0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting Mitochondria-Inflammation Circuit by \u03b2-Hydroxybutyrate Mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2026.113432_b0270","article-title":"Trigonelline improves metabolism and cardiac function of HFpEF mice via gut microbiome alterations-mediated AMPK activation","volume":"13","author":"Cheng","year":"2026","journal-title":"Adv Sci"},{"key":"10.1016\/j.diabres.2026.113432_b0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.tips.2025.02.005","article-title":"Visceral obesity and HFpEF: targets and therapeutic opportunities","volume":"46","author":"Li","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.diabres.2026.113432_b0095","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1515\/jbcpp-2022-0230","article-title":"Cellular cross talk between epicardial fat and cardiovascular risk","volume":"33","author":"Patel","year":"2022","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.diabres.2026.113432_b0100","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s12013-024-01353-2","article-title":"Farrerol alleviates diabetic cardiomyopathy by regulating AMPK-mediated cardiac lipid metabolic pathways in type 2 diabetic rats","volume":"82","author":"Tu","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.diabres.2026.113432_b0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4093\/dmj.2023.0110","article-title":"Primordial drivers of diabetes heart disease: comprehensive insights into insulin resistance","volume":"48","author":"Fan","year":"2024","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2026.113432_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-pathmechdis-111523-023405","article-title":"Contributions of inflammation to cardiometabolic heart failure with preserved ejection fraction","volume":"20","author":"Thorp","year":"2025","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.diabres.2026.113432_b0115","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"H S, Mv K, K I, I T, H Y, Js F.","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113432_b0120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2026.113432_b0125","first-page":"709","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm Res Off J Eur Histamine Res Soc Al"},{"key":"10.1016\/j.diabres.2026.113432_b0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41590-023-01733-5","article-title":"Metabolic waypoints during T cell differentiation","volume":"25","author":"Wilfahrt","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.diabres.2026.113432_b0135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171874","article-title":"Impaired T cell IRE1\u03b1\/XBP1 signaling directs inflammation in experimental heart failure with preserved ejection fraction","volume":"133","author":"Smolgovsky","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113432_b0140","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.2147\/JIR.S370483","article-title":"The NLRP3 inflammasome as a novel therapeutic target for cardiac fibrosis","volume":"15","author":"Fan","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.diabres.2026.113432_b0150","first-page":"1524","article-title":"Low-density neutrophils and neutrophil extracellular traps (NETs) are new inflammatory players in heart failure","volume":"40","author":"Dumont","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.diabres.2026.113432_b0155","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1080\/15384101.2015.1056947","article-title":"Cellular adaptation to nutrient deprivation: crosstalk between the mTORC1 and eIF2\u03b1 signaling pathways and implications for autophagy","volume":"14","author":"Wengrod","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.diabres.2026.113432_b0160","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","article-title":"Cardiac metabolism in HFpEF: from fuel to signalling","volume":"118","author":"Capone","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2026.113432_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107970","article-title":"Sirtuin-mediated modulation of cardiac fibrosis: Emerging molecular insights and therapeutic perspectives","volume":"221","author":"Cozzolino","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diabres.2026.113432_b0170","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113432_b0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12933-025-02734-4","article-title":"Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets","volume":"24","author":"Delalat","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113432_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167140","article-title":"Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a","volume":"1870","author":"Lou","year":"2024","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.diabres.2026.113432_b0185","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41569-025-01166-7","article-title":"Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets","volume":"22","author":"Mericskay","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.diabres.2026.113432_b0190","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011260","article-title":"O-GlcNAc transferase promotes compensated cardiac function and protein kinase a O-GlcNAcylation during early and established pathological hypertrophy from pressure overload","volume":"8","author":"Zhu","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabres.2026.113432_b0195","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.120.051911","article-title":"Excessive O-GlcNAcylation causes heart failure and sudden death","volume":"143","author":"Umapathi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113432_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120998","article-title":"Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment","volume":"309","author":"Koser","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.diabres.2026.113432_b0205","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/eurheartj\/ehab197","article-title":"Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies","volume":"42","author":"Hamdani","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2026.113432_b0210","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/ATVBAHA.118.311276","article-title":"Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease","volume":"38","author":"Hulshoff","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2026.113432_b0215","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI46277","article-title":"The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice","volume":"121","author":"Zhang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113432_b0225","doi-asserted-by":"crossref","first-page":"e8046","DOI":"10.15252\/emmm.201708046","article-title":"miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders","volume":"10","author":"Widlansky","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.diabres.2026.113432_b0230","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.3390\/ijms26146810","article-title":"Lactate in heart failure","volume":"26","author":"Gajewski","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113432_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103184","article-title":"Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation","volume":"73","author":"Wu","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.diabres.2026.113432_b0240","article-title":"Function and mechanism of histone \u03b2-hydroxybutyrylation in health and disease","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2026.113432_b0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12933-025-02707-7","article-title":"Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF","volume":"24","author":"Luo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113432_b0250","article-title":"The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF","volume":"15","author":"Zhou","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.diabres.2026.113432_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2026.102102","article-title":"S100A9 deficiency mitigates cardiac oxidative stress and improves function via SIRT3 in HFpEF mice","author":"Yu","year":"2026","journal-title":"Genes Dis"},{"key":"10.1016\/j.diabres.2026.113432_b0260","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1080\/10408398.2022.2124231","article-title":"Short-chain fatty acid: an updated review on signaling, metabolism, and therapeutic effects","volume":"64","author":"Rekha","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.diabres.2026.113432_b0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/nu18020321","article-title":"Gut microbiota and short-chain fatty acids in cardiometabolic HFpEF: mechanistic pathways and nutritional therapeutic perspectives","volume":"18","author":"Vacca","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.diabres.2026.113432_b0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12933-025-02771-z","article-title":"Type 2 diabetes worsens the outcome of ischemia\/reperfusion in female STEMI patients and female db\/db mice with HFpEFcardiometabolic phenotype","volume":"24","author":"Iveljic","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113432_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119213","article-title":"Roeters van Lennep JE. Lipid metabolism in women: a review","volume":"405","author":"van Oortmerssen","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2026.113432_b0285","first-page":"H14","article-title":"Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women","volume":"310","author":"Wei","year":"2016","journal-title":"Am J Phys Heart Circ Phys"},{"key":"10.1016\/j.diabres.2026.113432_b0290","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70107","article-title":"The X factor in Immunity: sex differences shaped by the X chromosome","volume":"338","author":"Radovanovic","year":"2026","journal-title":"Immunol Rev"},{"key":"10.1016\/j.diabres.2026.113432_b0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113432_b0300","first-page":"790","article-title":"Cardiometabolic phenotyping in heart failure: differences between patients with reduced vs","volume":"13","author":"Balletti","year":"2023","journal-title":"Preserved Ejection Fraction Diagn Basel Switz"},{"key":"10.1016\/j.diabres.2026.113432_b0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cjco.2025.01.012","article-title":"Unraveling heart failure phenotypes: a systematic review and meta-analysis of peak oxygen uptake and its determinants","volume":"7","author":"Tomczak","year":"2025","journal-title":"CJC Open"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:14:39Z","timestamp":1792804479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726003529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":74,"alternative-id":["S0168822726003529"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113432","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolite sensing in cardiometabolic HFpEF: mechanisms and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113432"}}